Scinai Immunotherapeutics (SCNI) Return on Assets [ROA] (2019 - 2026)
Scinai Immunotherapeutics (SCNI) posted Return on Assets [ROA] of -48.19% for Q2 2026, up 9.95 percentage points from the prior quarter.
Powered by 
Analysis
Scinai Immunotherapeutics (SCNI) Return on Assets [ROA] (2019 - 2026) Analysis & Trends
For FY2025, Scinai Immunotherapeutics' Return on Assets [ROA] came in at -87.43%, down 118.45 percentage points from FY2024.
- Annual Return on Assets [ROA] shows a five-year change of -70.02 percentage points (FY2020 to FY2025).
- In prior years, Scinai Immunotherapeutics' Return on Assets [ROA] was 31.02% in FY2024 (+60.21 pp), -29.19% in FY2023 (-48.80 pp), 19.61% in FY2022 (+71.31 pp) and -51.69% in FY2021 (-34.29 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Assets [ROA] since Q4 2024.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q4 2024, with a gain of 138.07 percentage points; the weakest was Q3 2023, with a drop of 260.02 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 2.00% |
| 10 | Scinai Immunotherapeutics | 112,563.86 | -8.15 Mn | -1.25 Mn | -48.19% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -48.19% |
| Mar 31, 2026 | -58.14% |
| Dec 31, 2024 | 98.59% |
| Sep 30, 2024 | 69.41% |
| Jun 30, 2024 | -52.39% |
| Mar 31, 2024 | -40.07% |
| Dec 31, 2023 | -69.85% |
| Sep 30, 2023 | -154.52% |
| Jun 30, 2023 | -37.26% |
| Mar 31, 2023 | -35.05% |
| Dec 31, 2022 | -32.33% |
| Sep 30, 2022 | 229.75% |
| Dec 31, 2021 | 48.75% |
| Sep 30, 2021 | -118.20% |
| Dec 31, 2020 | 36.06% |
| Sep 30, 2020 | 9.12% |
| Dec 31, 2019 | -93.55% |
| Sep 30, 2019 | -94.41% |
| Jun 30, 2019 | -100.32% |
API Access
Scinai Immunotherapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SCNI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "SCNI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SCNI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();